Patents by Inventor Sandra Tobias

Sandra Tobias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Development of new selective estrogen receptor modulators
    Patent number: 8263661
    Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: September 11, 2012
    Assignees: The Regents of the University of California, Oregon Health & Science University
    Inventors: Thomas S. Scanlan, Martin J. Kelly, Jian Qiu, Sandra Tobias, Oline K. Ronnekleiv
  • Development of New Selective Estrogen Receptor Modulators
    Publication number: 20110152226
    Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
    Type: Application
    Filed: September 15, 2010
    Publication date: June 23, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Thomas S. Scanlan, Martin J. Kelly, Jian Qiu, Sandra Tobias, Oline K. Ronnekleiv
  • Development of new selective estrogen receptor modulators
    Publication number: 20080214609
    Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
    Type: Application
    Filed: February 6, 2007
    Publication date: September 4, 2008
    Inventors: Thomas S. Scanlan, Martin J. Kelly, Jian Qiu, Sandra Tobias, Oline K. Ronnekleiv
  • Development of new selective estrogen receptor modulators
    Patent number: 7196119
    Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: March 27, 2007
    Assignees: The Regents of the University of California, Oregon Health & Science University
    Inventors: Thomas S. Scanlan, Martin J. Kelly, Jian Qiu, Sandra Tobias, Oline K. Ronnekleiv
  • Phosphoramidates and methods therefor
    Publication number: 20050171060
    Abstract: Novel phosphoramidate derivatives of hydroxy functional or amino functional compounds, including amino acids, peptides, peptidomimetics and nucleotide analogs, are described. The compounds enable enhanced intracellular delivery of drugs as their corresponding phosphate esters or amides. Described phosphoramidate compounds exhibit antiproliferative activity. Pharmaceutical formulations are provided for treatment of cancers.
    Type: Application
    Filed: February 8, 2005
    Publication date: August 4, 2005
    Inventors: Richard Borch, Hugo Garrido-Hernandez, Sandra Tobias
  • Development of new selective estrogen receptor modulators
    Publication number: 20050113453
    Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
    Type: Application
    Filed: October 20, 2004
    Publication date: May 26, 2005
    Inventors: Thomas Scanlan, Martin Kelly, Jian Qiu, Sandra Tobias, Oline Ronnekleiv